Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2025-12-30 @ 6:05 AM
Study NCT ID:
NCT05018403
Status:
COMPLETED
Last Update Posted:
2022-01-12
First Post:
2021-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-human Trial With Single-dose C5a-neutralizing AON-D21 in Healthy Male Subjects
Sponsor:
Aptarion Biotech AG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
S-D21-C100
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None